J. B. Chemicals & Pharmaceuticals Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
J. B. Chemicals & Pharmaceuticals şirketinin toplam hissedar öz sermayesi ₹32.1B ve toplam borcu ₹816.4M olup, bu da borç-öz sermaye oranını 2.5% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹40.3B ve ₹8.2B dir. J. B. Chemicals & Pharmaceuticals 'in FAVÖK'ü ₹8.1B faiz karşılama oranı 33.1 dur. Şirketin ₹4.2B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler
2.5%
Borç/özkaynak oranı
₹816.40m
Borç
| Faiz karşılama oranı | 33.1x |
| Nakit | ₹4.17b |
| Eşitlik | ₹32.12b |
| Toplam yükümlülükler | ₹8.17b |
| Toplam varlıklar | ₹40.29b |
Son finansal sağlık güncellemeleri
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29Recent updates
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Nov 09J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price
Sep 24Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation
Aug 15J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 11These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: JBCHEPHARM 'nin kısa vadeli varlıkları ( ₹19.1B ) kısa vadeli yükümlülüklerini ( ₹6.2B ) aşıyor.
Uzun Vadeli Yükümlülükler: JBCHEPHARM şirketinin kısa vadeli varlıkları ( ₹19.1B ) uzun vadeli yükümlülüklerini ( ₹2.0B ) aşmaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: JBCHEPHARM şirketinin toplam borcundan daha fazla nakiti var.
Borcun Azaltılması: JBCHEPHARM 'nin borç/öz sermaye oranı son 5 yılda 3% seviyesinden 2.5% seviyesine düştü.
Borç Kapsamı: JBCHEPHARM 'nin borcu işletme nakit akışı ( 912.6% ) tarafından iyi bir şekilde karşılanmaktadır.
Faiz Kapsamı: JBCHEPHARM 'in borcuna ilişkin faiz ödemeleri EBIT ( 33.1 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.